Vinorelbine Interactions
There are 498 drugs known to interact with vinorelbine, along with 6 disease interactions. Of the total drug interactions, 75 are major, 405 are moderate, and 18 are minor.
- View all 498 medications that may interact with vinorelbine
- View vinorelbine disease interactions (6)
Most frequently checked interactions
View interaction reports for vinorelbine and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Acetylsalicylic Acid (aspirin)
- Adriamycin (doxorubicin)
- Alimta (pemetrexed)
- Aloxi (palonosetron)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Celebrex (celecoxib)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Decadron (dexamethasone)
- Demerol (meperidine)
- Fentanyl Transdermal System (fentanyl)
- Gemzar (gemcitabine)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Lyrica (pregabalin)
- Neupogen (filgrastim)
- OxyContin (oxycodone)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- Zofran (ondansetron)
Vinorelbine disease interactions
There are 6 disease interactions with vinorelbine which include:
- pulmonary dysfunction
- hepatic dysfunction
- infections
- myelosuppression
- gastrointestinal disorders
- peripheral neurotoxicity
Report options
QR code containing a link to this page
More about vinorelbine
- vinorelbine consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.